Bulking agent (isomalt), sweetener (xylitol), L. reuteri DSM 17938, palm oil, natural lemon flavoring and flavor enhancer (citric acid). One tablet consists of a minimum of 100 million live L. reuteri Protectis. Net weight per tablet, 450 mg. Excessive consumption may have a laxative effect due to the content of sweeteners in the product.
CasenBiotic chewable tablets
Probiotic gut health
CasenBiotic chewable tablets is a food supplement containing the patented lactic acid bacterium Lactobacillus reuteri Protectis®/TM (L. reuteri DSM 17938) that helps the good microorganisms restore a natural balance in the gut. Because L. reuteri Protectis naturally colonizes humans it has a strong adaptation to persist and interact with humans.
Storage: Store in a dry place, not above room temperature (max 25 °C/77 °F). Keep out of reach of children.
Pregnancy and breast-feeding: The product can be used during pregnancy and breast-feeding.
1–2 chewable tablets per day. Use regularly for good gut health or when temporary stomach dis comfort occurs. Recommended daily dose should not be exceeded. This product should not be used as a substitute for a varied diet.
The spots are not dangerous and the product can still be used. BioGaia Protectis tablets contains ascorbic acid, which is an antioxidant that contributes to the stability of the tablets. Over time the ascorbic acid oxidizes and the color becomes darker. This darkening is seen as small “spots” on the tablet.
Multi-strain products containing several strains in high doses do not necessarily have a better effect than a single-strain product. Important criteria when choosing a probiotic product are:
• The probiotic bacteria must be defined on strain level
• The probiotic product must have been tested in human clinical studies, with the same dose and with the same bacterial strain(s) as in the commercial product.
Lactobacillus reuteri (L. reuteri) is a probiotic bacteria that has co-evolved with humans since the beginning of time, and because of that it is adapted to its host. L. reuteri is among the first bacterial species to naturally become established in the microbiota of the newborn. BioGaia probiotic products with L. reuteri are among the most scientifically well-documented probiotics in the world with regard to both efficacy and safety. To date 202 clinical studies with BioGaia’s L. reuteri-strains have been performed in more than 17,200 people of all ages. Positive results have been shown for several gastrointestinal disorders and oral health. Results have been published in 180 articles in scientific journals (February 2019).
Read more about Lactobacillus reuteri.
Exposure to high temperatures and/or high humidity will significantly shorten the shelf-life of the product. However, the product will still be safe to use.
Probiotics are good bacteria that can be found in dietary supplements and sometimes in dairy products. Probiotics are defined as ”live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.” (WHO/FAO 2002, Hill C et al. 2014). An important criterium for qualifying as a true probiotic is that health benefits have been proven in clinical studies. Furthermore, a probiotic product must contain the same bacterial strain(s) and the same dose that was used in the clinical studies.
All BioGaia products are free from common allergens such as egg, peanuts, tree nuts, fish, shellfish and soy.
Our products are sold by distribution partners in around 100 countries. Usually, they are sold through the major pharmacy chains. For information on where to buy our products, please contact our distribution partner in your country.
In BioGaia Protectis tablets neither milk protein nor lactose are detectable, and the gluten level is below EU limit value for gluten-free products. As food regulation varies from country to country, the product labelling may differ.